A gene-editing therapy for sickle cell disease was approved by US regulators, a milestone for the DNA-modifying technology Crispr. Crispr Co-Inventor, 2020 Nobel Prize winner in chemistry, and Innovative Genomics Institute founder Jennifer Doudna joins Caroline Hyde and Ed Ludlow on “Bloomberg Technology.”
——–
Like this video? Subscribe to Bloomberg Technology on YouTube:
https://www.youtube.com/channel/UCrM7B7SL_g1edFOnmj-SDKg
Watch the latest full episodes of “Bloomberg Technology” with Caroline Hyde and Ed Ludlow here: https://tinyurl.com/ycyevxda
Get the latest in tech from Silicon Valley and around the world here:
https://www.bloomberg.com/technology
Connect with us on…
Twitter: https://twitter.com/technology
Facebook: https://www.facebook.com/BloombergTechnology
Instagram: https://www.instagram.com/bloombergbusiness/
